Literature DB >> 7913545

Positive and negative regulatory elements in the human erbB-2 gene promoter.

Y Chen1, G N Gill.   

Abstract

Analysis of the proximal promoter of the human erbB-2 gene identified a 100 bp region that enhanced activity of the proximal TATA box 200-fold. DNase I footprinting mapped three Sp1 binding sites within this 100 bp region but only one of these sites was of high affinity and strongly correlated to Sp1-dependent activity in vivo. This Sp1 site overlapped the distal of two similar palindromic sequences. The proximal palindrome did not bind Sp1 but overlaps the CAAT box. When placed in the context of a heterologous promoter, the palindrome functioned as a positive response element. However, removal of the 5' half of the proximal palindrome increased promoter activity indicating that it functions as an inhibitory element within the erbB-2 context. Using electrophoretic mobility shift assays, a nuclear protein was detected that bound to either the 5' or 3' half of the palindrome but not to both. Analysis of the function of mutant sequences revealed maximal activity when both halves of the palindrome were intact with decreased but significant activity persisting when the 3' half of the palindrome was disrupted. Disruption of the 5' half of the palindrome impaired activity to a greater extent. These studies indicate erbB-2 promoter activity is positively regulated by Sp1 and negatively regulated in a position-dependent context by a protein that binds to a palindromic sequence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913545

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Investigation of the role of DNA methylation in the expression of ERBB2 in human myocardium.

Authors:  Adolfo Quiñones-Lombraña; Rachael Hageman Blair; Javier G Blanco
Journal:  Gene       Date:  2017-07-21       Impact factor: 3.688

3.  Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks.

Authors:  R R Beerli; D J Segal; B Dreier; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

4.  Transcriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins.

Authors:  HongBin Wang; Alvaro Gutierrez-Uzquiza; Rachana Garg; Laura Barrio-Real; Mahlet B Abera; Cynthia Lopez-Haber; Cinthia Rosemblit; Huaisheng Lu; Martin Abba; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

5.  A novel HER2 gene body enhancer contributes to HER2 expression.

Authors:  Q Liu; M V Kulak; N Borcherding; P K Maina; W Zhang; R J Weigel; H H Qi
Journal:  Oncogene       Date:  2017-10-16       Impact factor: 9.867

6.  Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.

Authors:  Patrick R Benusiglio; Fabienne Lesueur; Craig Luccarini; Donald M Conroy; Mitul Shah; Douglas F Easton; Nick E Day; Alison M Dunning; Paul D Pharoah; Bruce Aj Ponder
Journal:  Breast Cancer Res       Date:  2005-01-12       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.